KLRI Home > Research > Current > Testosterone Study (TEAAM)

Testosterone Study (TEAAM)

Snapshot

Testosterone's Effects on the Progression of Atherosclerosis in Aging Men (TEAAM): The TEAAM Study is a randomized, placebo-controlled, double-blind examination of healthy male volunteers ages 60 and older with testosterone levels less than 450 ng/dl. This multi-center study will recruit a total of 320 participants (180 at KLRI and 140 at the Los Angeles and Boston centers) over a three-year period, and the selected men will be treated for three years. The participants will be placed into two groups. The first group will receive AndroGel®, an FDA-approved testosterone gel for external application. The second group will receive placebo gel consisting of the alcohol base used in AndroGel® without the testosterone. All participants will be seen during 10 formal evaluation sessions for data collection procedures and five additional brief visits for study monitoring, including a compliance check, a review for adverse effects, and a brief physical exam.

Extended Description